- Home
- Staff Profiles & Phone Book
- About the Department
- Study Anatomy
- Study Neuroscience
- Research
- UCC Anatomical Donations
- Biosciences Imaging Centre
- BSc Medical and Health Sciences
- News & Events
- BRAIN AWARENESS WEEK 2023
- NEWS ARCHIVE 2023
- News Archive 2022
- News Archive 2021
- News Archive 2020
- News Archive 2019
- News Archive 2018
- News archive 2017
- News Archive 2016
- News Archive2015
- News Archive 2014
- News Archive 2013
- News Archive 2012
- News Archive 2011
- Department Events and Conferences
- Seminar series 2019_2020
- Recent Publications
- photo galleries
- Department of Anatomy and Neuroscience Contact Us
News Archive 2014
Research links between Dentistry and Department of Anatomy and Neuroscience
Dr. Eric Downer, Dept. Anatomy and Neuroscience, has published a new article with colleagues in Cork University Dental School and Hospital in the International Journal of Biochemistry and Cell Biology.
Dr. Downer, alongside clinical collaborators Dr. Joseph McKenna and Dr. Christine McCreary, and Dental student Mr. Patrick McDonough, have published a paper entitled “Neuropathic orofacial pain: cannabinoids as a therapeutic avenue”. The article addresses the potential of cannabinoid compounds as a novel therapy for neuropathic orofacial pain disorders, including burning mouth syndrome, persistent idiopathic facial pain, trigeminal neuralgia and postherpetic neuralgia.
Dr. Downer say’s “We have focused on common neuropathic pain conditions observed in the Dental clinic, the pathophysiology of which are still largely unclear. Treatment options for these conditions tend to have limited efficacy with a great amount of inter-patient variability and poorly tolerated side effects. The cannabinoid system ticks a host of boxes for efficacy in the treatment of neuropathic pain, and hence we have investigated the potential use of cannabinoids in the treatment of symptoms associated with neuropathic orofacial pain”.
Dr. Downer, alongside Drs McKenna and McCreary, are currently planning a programme of patient-orientated research to identify novel inflammatory targets contributing to the progression of neuropathic orofacial pain disorders.
To read the article, click here: